Running A Life Science R&D Business with Dr. Aaron Sato, CSO of Twist Biopharma
This is the second article in a three-part series of Q&A conversations with Dr. Aaron Sato, CSO of Twist Biopharma, a division of Twist Bioscience. Part one focused on how Twist is adapting to the ongoing COVID-19 crisis and appeared in the spring edition of Benchtalk Journal. Part three will focus on Dr. Sato’s career as well as the unique approach Twist Biopharma is taking to antibody discovery and will appear in the fall edition of Benchtalk Journal.
[Read More]
